Lumos Pharma Overview
- Year Founded
-
1999
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Buyout/LBO
- Latest Deal Amount
-
$28M
Lumos Pharma General Information
Description
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.
Contact Information
Website
www.lumos-pharma.comCorporate Office
- 4200 Marathon Boulevard
- Suite 200
- Austin, TX 78756
- United States
Corporate Office
- 4200 Marathon Boulevard
- Suite 200
- Austin, TX 78756
- United States
Lumos Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Buyout/LBO | 12-Dec-2024 | $28M | Completed | Generating Revenue/Not Profitable | ||
| 6. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 5. Reverse Merger | 18-Mar-2020 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 23-Aug-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 06-Apr-2016 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2015 | $14M | Completed | Generating Revenue | ||
| 1. Later Stage VC (Series A) | 24-Jan-2014 | $14M | $14M | Completed | Generating Revenue |
Lumos Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Lumos Pharma Comparisons
Industry
Financing
Details
Lumos Pharma Competitors (45)
One of Lumos Pharma’s 45 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Abeona Therapeutics | Corporation | Cleveland, OH | ||||
| SpringWorks Therapeutics | Formerly VC-backed | Stamford, CT | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| Harmony Biosciences | Formerly VC-backed | Plymouth Meeting, PA |
Lumos Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lumos Pharma Patents
Lumos Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022485048-A1 | Compactable oral formulations of ibutamoren | Pending | 03-Nov-2022 | ||
| US-11969416-B1 | Compactable oral formulations of ibutamoren | Active | 03-Nov-2022 | ||
| US-20240156793-A1 | Compactable oral formulations of ibutamoren | Active | 03-Nov-2022 | ||
| US-20240245663-A1 | Compactable oral formulations of ibutamoren | Pending | 03-Nov-2022 | ||
| AU-2019222736-A1 | Compositions for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis | Active | 14-Feb-2018 | A61K31/4439 |
Lumos Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lumos Pharma Investments & Acquisitions (2)
Lumos Pharma’s most recent deal was a Merger/Acquisition with Newlink Genetics for . The deal was made on 18-Mar-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Newlink Genetics | 18-Mar-2020 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Ammonett Pharma (LUM-201) | 31-Jul-2018 | Corporate Asset Purchase | Buildings and Property |
Lumos Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Lumos Pharma FAQs
-
When was Lumos Pharma founded?
Lumos Pharma was founded in 1999.
-
Where is Lumos Pharma headquartered?
Lumos Pharma is headquartered in Austin, TX.
-
What is the size of Lumos Pharma?
Lumos Pharma has 45 total employees.
-
What industry is Lumos Pharma in?
Lumos Pharma’s primary industry is Drug Discovery.
-
Is Lumos Pharma a private or public company?
Lumos Pharma is a Private company.
-
What is the current valuation of Lumos Pharma?
The current valuation of Lumos Pharma is .
-
What is Lumos Pharma’s current revenue?
The current revenue for Lumos Pharma is .
-
How much funding has Lumos Pharma raised over time?
Lumos Pharma has raised $48M.
-
Who are Lumos Pharma’s competitors?
Genentech, Abeona Therapeutics, SpringWorks Therapeutics, Alnylam Pharmaceuticals, and Harmony Biosciences are some of the 45 competitors of Lumos Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
